News for Motion Acquisition Corp. (MOTNW)

Motion Acquisition (DCGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

DocGo plunges after Fuzzy Panda Research shorts the stock

The no-bid contract is only one component of the company's dealings that are under fire from elected officials.

Plus:Hackensack Meridian Health invests $30M in treatment for severe depression and autismCity lobbyists sue health care company, alleging they reneged on contractMayor announces collaboration to help NYPD officers interact with students with autism

Here is how DocGo Inc. (DCGO) and Shockwave Medical (SWAV) have performed compared to their sector so far this year.

DocGo is well positioned to exploit the 'last mile' care niche. Read more on a potential investment in this emerging healthcare company.

Read DocGo (NASDAQ:DCGO) Stock Rating Upgraded by Zacks Investment Research at ETF Daily News

Read Stock Analysts’ Upgrades for June 8th (ARLP, ASLE, BDC, BKE, BNPQY, CELTF, CLIR, CNTB, COWN, CRGY) at ETF Daily News

Read Analysts’ Recent Ratings Updates for DocGo (DCGO) at ETF Daily News

Read Research Analysts’ Updated EPS Estimates for May 30th (BZZUF, CIADY, CLS, CPT, CRRFY, CRZBY, CSR, CSWC, CTTAY, CZNC) at ETF Daily News

Read DocGo (NASDAQ:DCGO) Upgraded to “Hold” by Zacks Investment Research at ETF Daily News

QFTA rises slightly on the news, warrants +78%. SPAC IPO deluge continues as nearly $3B in SPACs have priced in the first 4 days of November.